Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls

Biol Psychiatry. 1993 Oct 15;34(8):507-14. doi: 10.1016/0006-3223(93)90192-g.

Abstract

The effects of apomorphine and methylphenidate on thought disorder, as measured by the Thought Disorder Index, in schizophrenic patients and in normal controls were evaluated. Methylphenidate, but not apomorphine, increased thought disorder in patients. Neither drug significantly increased thought disorder in controls.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Apomorphine / pharmacology*
  • Brain / drug effects
  • Brain / physiopathology
  • Dopamine / physiology*
  • Female
  • Humans
  • Male
  • Methylphenidate / pharmacology*
  • Psychiatric Status Rating Scales
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Thinking / drug effects*
  • Thinking / physiology

Substances

  • Methylphenidate
  • Apomorphine
  • Dopamine